Most cases (14 of 19) had relapsed with distant metastasis There was a significant difference in the detection of BRAF mutant status between UM (1 of 12, 8.3%) and CM patients (4 of 7, 57.1%) (p = 0.038). The gene discussed is BRAF; the disease is cutaneous mastocytosis.